Background: A small dose of the Bordetella pertussis vaccine is used as an adjuvant for the induction of experimental autoimmune encephalomyelitis (EAE) in mice. The effects of two doses of the Pertussis vaccine on clinical signs, antibody titers, and the expression of CD4 and MHC molecules in brain tissue sections of mice with EAE were examined. Methodology: EAE was induced by spinal cord homogenate in Complete Freund adjuvant (CFA) in 30 of 40 C57BL/6 mice divided in groups: EAE mice with a small adjuvant dose of the Pertussis vaccine (EAE-1), EAE mice with a human dose of the Pertussis vaccine (EAE-2), EAE mice (EAE-3). Results: None of the mice from the EAE groups progressed to severe EAE. Five mice from the EAE-2 group were found dead on the 13th day post-immunization. A significant increase of anti-MOG (myelin oligodendrocyte glycoprotein) antibodies was detected in mice with EAE compared to non-treated mice. Myelin loss and brain tissue lesions were observed in EAE-1 and EAE-2 mice compared to EAE-3 and non-treated mice. A high expression of MHC-II and a mild expression of MHC-I was detected in the brains of mice with EAE. No expressions were detected in intact brains. Scattered CD4-positive cells were detected in the brains of EAE-1 and EAE-2 mice compared to EAE-3 and non-treated mice. Conclusion: A small dose of the Bordetella pertussis vaccine could maintain the developed clinical signs and histological changes in mice with EAE, while higher doses led to additional adverse effects. The expression of CD4 and MHC class I and II molecules, as well as an increase in anti-MOG antibodies could be used as markers capable of monitoring the development and progression of EAE.
Introduction
Human vaccines can induce autoimmunity when administered with autoantigens, exacerbate autoimmunity when given alone, and can even induce autoimmunity when administered without autoantigens [1, 2] . The Bordetella pertussis bacterium produces pertussis toxin, which represents its main virulence factor. However, the pertussis vaccine has been shown to be an adjuvant for the induction of a number of autoimmune diseases. In the animal model of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), the Bordetella pertussis vaccine and pertussis toxin are used to increase disease incidence and severity when administered simultaneously with the autoimmune challenge [3] [4] [5] . It is suggested that the pro-inflammatory activity of Bordetella pertussis is mainly attributed to an increased permeabilization of the blood-brain barrier leading to an influx of immune cells into the CNS [6] . + T cells allows them to cross the blood-brain barrier more efficiently than naïve T cells [10, 11] .
The altered expression of MHC class I and/or II antigens has been associated with a variety of disorders with neurological symptoms, including MS and EAE. It is suggested that MHC class I has a role in the normal development of the CNS, as well as the immune response in EAE [12] , while the expression of MHC class II molecule acts as a stimulus for the activation of CD4 + T cells [13] . MHC class II antigen expression is always increased in EAE, and MHC class II-positive cells are abundant in and around active EAE lesions [13, 14] .
Humoral immunity plays a major role in disease pathogenesis. Some studies reported a pathogenic role of autoantibodies directed against one or several myelin proteins, while other studies suggest that natural autoantibodies could mediate the repair to myelin membranes (i.e. remyelination/axon protection) [15] indicating that the detection of antibodies may be useful in assessing the clinical course of the disease. Even though the presence of the antibody response within the CNS in MS patients is well established, the pathogenic role of antibodies still remains obscure and their antigenic targets have yet to be determined [16, 17] .
In the present study, the effects of two different doses of the Bordetella pertussis vaccine on the regulation of EAE were examined in C57BL/6 mice through the monitoring of EAE clinical signs, antibody titers and the expression of CD4 and MHC molecules in the brain tissue of the mice. 
Experimental procedures

Statistical evaluation
The differences of antibody titers were 
Tissue analysis
The analysis of brain sections was performed by capturing images of sections using a BH2 research microscope (Olympus Optical Co.
Ltd, Tokyo, Japan) equipped with a Color View III digital camera (Olympus). Analysis Docu software (Olympus) was used to acquire images. 
Results
Clinical signs of EAE
Discussion
In this study, the effects of two different Hoftberger et al. [34] showed that both class The expression of MHC antigens is dependent upon the type of tissue injury, the stage and activity of the lesions, and the genetic background [35] [36] [37] . In EAE microglia proliferate vigorously and show a strong expression of MHC-I and II antigens [32] , which might, in this case, suggest that MHC molecules found in the brain tissue were mainly expressed on microglia. Knowing that the expression of MHC molecules on microglia is in close relation with the development of the EAE clinical signs, we found our results to be consistent with previous findings [13, 32] .
Conclusion
In 
